Vimarsana
Biggest News Aggregation in the World

Trex Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trex Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trex Bio Today - Breaking & Trending Today

Enterome Appoints Industry Veteran Dr. Peter Hirth to its Board of Directors - Vimarsana News

Enterome Appoints Industry Veteran Dr. Peter Hirth to its Board of Directors

PARIS, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Enterome, a clinical-stage company developing first-in-class immunomodulatory drugs for solid and liqui...

Teasing Apart Multiple Biologic Failure in Psoriasis, PsA - Vimarsana News

Teasing Apart Multiple Biologic Failure in Psoriasis, PsA

'Tough-to-treat psoriasis remains a challenge despite newer therapies ... Why do we still have this sub-population of patients who seem to be refractory?'

Press Release: Sanofi announces changes to its Executive Committee -Today at 01:31 am - Vimarsana News

Press Release: Sanofi announces changes to its Executive Committee -Today at 01:31 am

Sanofi announces changes to its Executive Committee Paris, August 31st, 2023. Sanofi announces the following changes to its Executive Committee: Houman Ashrafian is appointed as Head of Research &...

What Factors Cause Multiple Biologic Failure in Psoriasis? - Vimarsana News

What Factors Cause Multiple Biologic Failure in Psoriasis?

Female sex, hyperlipidemia, Medicaid insurance, earlier year of biologic initiation, shorter duration of psoriasis, and prior nonbiologic systemic therapy use were associated with multiple biologic failure.

Adjuvant Pembrolizumab Continues to Provide Survival Benefit in Stage IIB/C Melanoma - Vimarsana News

Adjuvant Pembrolizumab Continues to Provide Survival Benefit in Stage IIB/C Melanoma

Pembrolizumab led to sustained improvements in recurrence-free survival and distant metastasis-free vs placebo as adjuvant therapy in patients with resected stage IIB or IIC melanoma